Concepedia

Kelly R. Bales

KR

Statistics

Publications

107

Citations

20.5K

H-Index

67

Active since

1992

Affiliations

Eli Lilly (United States)(Current)

Washington University in St. Louis

Indiana University – Purdue University Indianapolis

Pfizer (United States)

Indiana University School of Medicine

Kelly R. Bales is an author at Eli Lilly (United States) specializing in neuroscience, life sciences, and neurodegenerative diseases.

Publications per year

1992–2019

107

Publications

107

Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease

Ronald B. DeMattos, Kelly R. Bales, David J. Cummins et al. · Proceedings of the National Academy of Sciences · 2001 · 1.3K citations · Full text

, , +17

Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo

John R. Cirrito, Kelvin A. Yamada, Mary Beth Finn et al. · Neuron · 2005 · 1.3K citations · Full text

, , +10

Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance

Joseph M. Castellano, Jungsu Kim, Floy R. Stewart et al. · Science Translational Medicine · 2011 · 1.2K citations

, , +9

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

David M. Holtzman, Kelly R. Bales, Tanya Tenkova et al. · Proceedings of the National Academy of Sciences · 2000 · 943 citations

, , +17

Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model

Jean‐Cosme Dodart, Kelly R. Bales, Kimberley S. Gannon et al. · Nature Neuroscience · 2002 · 859 citations

, , +10

1–5 of 107